From Trial to Target Populations — Calibrating Real-World Data von Najafzadeh, Mehdi, Schneeweiss, Sebastian

Volltext

Increasing incidence associated with herpes zoster infection in British Columbia, Canada von Marra, Fawziah, Chong, Mei, Najafzadeh, Mehdi

Volltext

Competition and price among brand-name drugs in the same class: A systematic review of the evidence von Sarpatwari, Ameet, DiBello, Jonathan, Zakarian, Marie, Najafzadeh, Mehdi, Kesselheim, Aaron S

Volltext

Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial von Lester, Richard T, Dr, Ritvo, Paul, PhD, Mills, Edward J, PhD, Kariri, Antony, BSc, Karanja, Sarah, BSc, Chung, Michael H, MD, Jack, William, DPhil, Habyarimana, James, PhD, Sadatsafavi, Mohsen, MD, Najafzadeh, Mehdi, MSc, Marra, Carlo A, PharmD, Estambale, Benson, MBChB, Ngugi, Elizabeth, PhD, Ball, T Blake, PhD, Thabane, Lehana, PhD, Gelmon, Lawrence J, MD, Kimani, Joshua, MBChB, Ackers, Marta, MD, Plummer, Francis A, Prof

Volltext

Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study von Patorno, Elisabetta, Pawar, Ajinkya, Wexler, Deborah J., Glynn, Robert J., Bessette, Lily G., Paik, Julie M., Najafzadeh, Mehdi, Brodovicz, Kimberly G., Déruaz‐Luyet, Anouk, Schneeweiss, Sebastian

Volltext

Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality von D’Andrea, Elvira, Ahnen, Dennis J., Sussman, Daniel A., Najafzadeh, Mehdi

Volltext

The independent contribution of executive functions to health related quality of life in older women von Davis, Jennifer C, Marra, Carlo A, Najafzadeh, Mehdi, Liu-Ambrose, Teresa

Volltext

Intensive versus standard blood pressure control in type 2 diabetes: a restricted mean survival time analysis of a randomised controlled trial von Shi, Sandra, Gouskova, Natalia, Najafzadeh, Mehdi, Wei, Lee-Jen, Kim, Dae Hyun

Volltext

Evolution of Herpes Zoster Vaccines and Their Economic Value von Najafzadeh, Mehdi

Volltext

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care von Patorno, Elisabetta, Pawar, Ajinkya, Franklin, Jessica M, Najafzadeh, Mehdi, Déruaz-Luyet, Anouk, Brodovicz, Kimberly G, Sambevski, Steven, Bessette, Lily G, Santiago Ortiz, Adrian J, Kulldorff, Martin, Schneeweiss, Sebastian

Volltext

The Potential Return on Public Investment in Detecting Adverse Drug Effects von Huybrechts, Krista F., Desai, Rishi J., Park, Moa, Gagne, Joshua J., Najafzadeh, Mehdi, Avorn, Jerry

Volltext

Future impact of various interventions on the burden of COPD in Canada: a dynamic population model von Najafzadeh, Mehdi, Marra, Carlo A, Lynd, Larry D, Sadatsafavi, Mohsen, FitzGerald, J Mark, McManus, Bruce, Sin, Don

Volltext

Need for Speed: An Efficient Algorithm for Calculation of Single-Parameter Expected Value of Partial Perfect Information von Sadatsafavi, Mohsen, MD, PhD, Bansback, Nick, PhD, Zafari, Zafar, MSc, Najafzadeh, Mehdi, MA, PhD, Marra, Carlo, PharmD, PhD

Volltext

Cost-Effectiveness of Using a Molecular Diagnostic Test to Improve Preoperative Diagnosis of Thyroid Cancer von Najafzadeh, Mehdi, PhD, Marra, Carlo A., PharmD, PhD, Lynd, Larry D., PhD, Wiseman, Sam M., MD, FRCSC

Volltext

A Unified Framework for Classification of Methods for Benefit-Risk Assessment von Najafzadeh, Mehdi, PhD, Schneeweiss, Sebastian, MD, ScD, Choudhry, Niteesh, MD, PhD, Bykov, Katsiaryna, PharmD, MS, Kahler, Kristijan H., RPh, PhD, Martin, Diane P., PhD, Gagne, Joshua J., PharmD, ScD

Volltext

The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care von Patorno, Elisabetta, Najafzadeh, Mehdi, Pawar, Ajinkya, Franklin, Jessica M., Déruaz‐Luyet, Anouk, Brodovicz, Kimberly G., Santiago Ortiz, Adrian J., Bessette, Lily G., Kulldorff, Martin, Schneeweiss, Sebastian

Volltext

Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs: A Simulation Study von Gagne, Joshua J., PharmD, ScD, Najafzadeh, Mehdi, PhD, Choudhry, Niteesh K., MD, PhD, Bykov, Katsiaryna, PharmD, MS, Kahler, Kristijan H., PhD, Martin, Diane, PhD, Rogers, James R, Schneeweiss, Sebastian, MD, ScD

Volltext

Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data von Gagne, Joshua J., PharmD, ScD, Bykov, Katsiaryna, PharmD, MS, Najafzadeh, Mehdi, PhD, Choudhry, Niteesh K., MD, PhD, Martin, Diane P., PhD, Kahler, Kristijan H., PhD, Rogers, James R., BA, BS, Schneeweiss, Sebastian, MD, ScD

Volltext

ENHANCING RANDIMIZED CONTROLLED TRIALS BY LINKING THEM TO REAL-WORLD DATA von Najafzadeh, Mehdi, Shimamura, Akiko, McConnochie, Ben, Demirci, Sevtap

Volltext

Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British... von Johnston, Karissa M., PhD, Marra, Carlo A., PhD, Connors, Joseph M., MD, Najafzadeh, Mehdi, MSc, Sehn, Laurie, MD, Peacock, Stuart J., DPhil

Volltext